Antifibrotic treatment adherence, efficacy and outcomes for patients with idiopathic pulmonary fibrosis in Spain: a real-world evidence study.

Ana Dolores Romero OrtizBeatriz María Jiménez-RodríguezCecilia López-RamírezÁngela López-BauzáMaría Pérez-MoralesJosé Antonio Delgado-TorralboCristina Villalba MoralBernardino Alcazar Navarrete

Published in: BMJ open respiratory research (2024)

in this real-world study, both pirfenidone and nintedanib showed similar efficacy profiles. Pirfenidone was associated with less treatment discontinuations due to side effects.

Keyphrases

idiopathic pulmonary fibrosis
interstitial lung disease

type diabetes
adipose tissue

rheumatoid arthritis

replacement therapy